期刊文献+

重组人血管内皮抑制素抑制角膜新生血管的实验研究 被引量:2

Inhibitive Effect of Recombinant Human Endostatin on Corneal Neovascularization
下载PDF
导出
摘要 目的探讨重组人血管内皮抑制素(恩度)对于缝线诱导兔角膜新生血管的抑制作用。方法新西兰大白兔24只,按随机数字表法分为3组(A组、B组、C组、每组8只),采用缝线诱导法制备兔角膜新生血管。A组采用球结膜下注射生理盐水0.1mL,隔日1次;B组采用球结膜下注射恩度0.1mL,隔日1次;C组采用球结膜下注射地塞米松0.1mL(0.5mg),隔日1次。每日裂隙灯下观察并测量角膜长出的角膜新生血管的长度,计算出新生血管的面积,共3周时间。结果 B组和C组各时间点新生血管的长度和面积均小于A组,差异有统计学意义(P<0.001)。B组在第13天和第18天新生血管的长度和面积均小于C组,差异有统计学意义(P<0.05)。结论动物实验表明恩度可以有效地抑制角膜新生血管的生长。 Objective To investigate the inhibitive effect of recombinant human endostatin(rHES) on corneal neovascularization(CNV) induced by suture.Methods Corneal neovascularization was induced by stitching cornea in 24 New Zealand white rabbits.These rabbits were randomly divided into three groups,with 8 rabbits in each group.Rabbits in group A,B and C were sub-conjunctivally injected with 0.1 mL normal saline,0.1 mL rHES and 0.1 mL dexamethasone(0.5 mg) every other day,respectively.The area of neovascularization was calculated by measuring vessel length of corneal neovascularization under slit-lamp illumination.The study lasted 3 weeks.Results Compared with group A,the vessel length and area of corneal neovascularization significantly decreased in group B and group C at each time point(P〈0.001).Compared with group B,the vessel length and area of corneal neovascularization obviously increased in group C on the thirteenth and eighteenth day(P〈0.05).Conclusion The rHES can effectively inhibit corneal neovascularization.
出处 《南昌大学学报(医学版)》 CAS 2012年第5期28-30,共3页 Journal of Nanchang University:Medical Sciences
关键词 角膜新生血管 恩度 地塞米松 动物 实验 corneal neovascularization; recombinant human endostatin; dexamethasone; animals,laboratory; rabbits;
  • 相关文献

参考文献5

二级参考文献41

  • 1赵长松,张泺,沈远萍.实验性兔角膜新生血管的防治研究[J].同济医科大学学报,1996,25(5):399-401. 被引量:2
  • 2束永前,王榕生,蒲骁麟.重组人血管内皮抑制素的抗肿瘤活性研究[J].实用临床医药杂志,2006,10(6):2-5. 被引量:11
  • 3罗明生 高天惠.药剂辅料大全[M].成都:四川科学技术出版社,1995.285-287.
  • 4Adamis AP,Shima DT.The role of vascular endothelial growth factor in ocular health and disease[J].Retina,2005,25(2):111-118.
  • 5Ferra N,Houck K,Jakeman L,et al.Molecular and biological properties of the vascular endothelial growth factor family of proteins[J].Endocr Rev,1992,13(1):18-32.
  • 6Miller KD,Chap LI,Holmes FA,et al.Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer[J].Clin Oncol,2005,23(4):792-799.
  • 7Yang JC,Haworth L,Sherry RM,et al.A randomized trial of bevacizumab,an anti-VEGF antibody,for metastatic renal cancer[J].N Engl J Med,2003,349(5):427-434.
  • 8Kang S,Chung SK.The effect of subconjunctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits[J].Cornea,2010,29(2):192-196.
  • 9Bahar I,Kaiserman I,McAllum P,et al.Subconjunctival bevacizumab injection for corneal neovascularization[J].Cornea,2008,27(2):142-147.
  • 10Nakao S,Hata Y,Miura M,et al.Dexamethasone inhibits interleukin-1β-induced corneal neovascularization[J].Am J Pathol,2007,171(3):1058-1065.

共引文献88

同被引文献26

  • 1FungAE,Rosenfeld P J,ReichelE. The international intravitreal Bevacizumab,Safety Survey:using the internet to assess drug safety worldwide[J].{H}British Journal of Ophthalmology,2006,(11):1344-1349.
  • 2SKovse th DK,Veuger MJ,Sorensen DR. dramatically inhibits endothelial Cell migration,vascular morphogenesis and perivascular cell recruitment in vivo[J].{H}Blood,2005,(07):1044-1051.
  • 3O'Reilly MS,Boehm T,Shing Y. Endostatin:an endogenous inhibitor ofangiogenesis and tumor growth[J].{H}CELL,1997,(02):277-285.
  • 4Hohenester E,Sasaki T,Mannk. Variable Zinc coordination in endostatin[J].{H}Molecular Biology,2000,(01):1-6.
  • 5Yamaguchi N,Anand-Apte B,Lee M. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding[J].{H}EMBO Journal,1999,(16):4414-4423.
  • 6Wang Kai,Wang Ke-zheng,Shen Bao-zhong. MR Reporter Gene Imaging of Endostatin Expression and Therapy[J].{H}Molecular Imaging and Biology,2010,(05):520-529.
  • 7Li J,Dong X,Xu Z. Endostatin gene therapy enhances the efficacy of paclitaxel to suppressbreast cancers and metastases in mice[J].{H}Biomedical Science,2008,(01):99-109.
  • 8Kim YM,Hwang S,Kim Y. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/ Flk-1[J].{H}Biological Chemistry,2002,(31):2787-2789.
  • 9Kim YM,Jang JW,Lee OH. Endostatin inhitbits endothelial and tumor cellular invasion byblocking the activation and catalytic activity ofmatrix metalloproteinase[J].{H}CANCER RESEARCH,2000,(19):5410-5413.
  • 10Hallai J,Dhanabal M,Karumanchi SA. Endostatin causes G1 arrest 0f endothelial cells through inhibition of cyclin D1[J].{H}Biological Chemistry,2002,(19):16464-16469.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部